21 February 2016 : Case report
[Retracted: 11 Jul 2017] A Boy with Relentless Pruritus: Job’s Syndrome
Kamran Khan DEF , Susan E. Wozniak E , Anna Lucia Giannone BE , Maria Elena Abdulmassih EDOI: 10.12659/AJCR.896798
Am J Case Rep 2016; 17:104-110
Abstract
BACKGROUND: Job’s syndrome (hyper IgE syndrome) is a very rare primary immunodeficiency disease that has an annual approximate incidence of less than 1/1,000,000. This manuscript aims to provide education regarding diagnosis and management strategies of this syndrome worldwide.
CASE REPORT: A 6-year-old boy was seen at the clinic secondary to persistent pruritus interfering with sleep. At the age of 2 months, the patient developed diffuse eczematous and desquamating skin lesions. He was subsequently diagnosed with atopic dermatitis and managed conservatively. From 2 months to 7 years of age, intermittent exacerbations of dermatitis persisted despite an aggressive treatment regimen. The serum IgE level increased exponentially over a period of 7 years, with a peak value of 57,400 IU/ml. Molecular genetic testing revealed a dominant negative mutation within the SH2 domain of the Signal Transducer and Activator of Transcription (STAT3) gene. The patient was subsequently diagnosed with Job’s syndrome. Management included proper skin care, prophylactic antibiotics, immunomodulating agents, and psychotherapy.
CONCLUSIONS: Job’s syndrome can often go unrecognized and masquerade as atopic dermatitis. Therefore, genetic testing for this condition should be obtained in all patients with treatment-refractory AD. Additionally, psychotherapy can be a successful management strategy for the grating psychological impact that can be imposed on children with excessive pruritus.
Keywords: Dermatitis, Atopic - diagnosis, Child, Diagnosis, Differential, Immunoglobulin E - blood, Job Syndrome - genetics, Mutation, Pruritus - etiology, STAT3 Transcription Factor - genetics
Retraction note
- Download PDF
- Order reprints
- Export Article
- Related articles
- Share by email
- Metrics
1,949 34
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953173
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953192
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952818
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953608
Most Viewed Current Articles
07 Dec 2021 : Case report
22,364,578
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
174,245
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
119,744
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
64,648
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
